Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio Inks Japan Distribution Deal

NEW YORK (GenomeWeb News) – CLC Bio today said that it has signed a distribution agreement for its next generation sequencing solutions in Japan.

The Aarhus, Denmark-based firm has signed Filgen as a reseller of its products in the Japanese market.

CLC Bio also named David Leangen as CEO of its CLC Bio Japan business.

"In 2009 we have experienced a considerable increase of interest in our solutions from Japan," Michael Heltzen, director of partner sales at CLC bio, said in a statement. "This is logically linked with the significant increase of Next Generation Sequencing instruments being installed, which in turn requires analysis capacity of the huge amounts of data - an area where we excel."

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.